Abstract

We report the generation of the human iPSC line LEIi008-A from a patient with retinitis pigmentosa-11 caused by a dominant nonsense mutation in the PRPF31 gene (NM_015629.3:c.1205C > A p.(Ser402Ter)). A second line, LEIi009-A, was generated from a related non-penetrant carrier of the same mutation with no retinal disease. Reprogramming of patient dermal fibroblasts using episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, shRNA for p53 and mir302/367 microRNA generated cell lines displaying pluripotent stem cell marker expression, a normal karyotype and the capability to differentiate into the three germ layer lineages.Resource tableUnlabelled TableUnique stem cell lines identifierLEIi008-ALEIi009-AAlternative names of stem cell lines1093ips4 (LEIi008-A)1374ips1 (LEIi009-A)InstitutionLions Eye Institute, Nedlands, Western Australia, AustraliaContact information of distributorSamuel McLenachan: smclenachan@lei.org.auFred Chen: fredchen@lei.org.auType of cell linesiPSCOriginHumanCell SourceDermal fibroblastsClonalityClonalMethod of reprogrammingEpisomalMultiline rationaleUnaffected mother and affected son carrying same dominant PRPF31 mutationGene modificationYesType of modificationHereditaryAssociated diseaseRetinitis Pigmentosa 11Gene/locusPRPF31/19q13.42Method of modificationN/AName of transgene or resistanceN/AInducible/constitutive systemN/ADate archived/stock dateLEIi008-A: 18/12/17; LEIi009-A: 17/11/17Cell line repository/bankhttps://hpscreg.eu/cell-line/LEIi008-Ahttps://hpscreg.eu/cell-line/LEIi009-AEthical approvalHuman Research Ethics Office, University of Western Australia (RA/4/1/7916)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.